SANA Stock Analysis: Buy, Sell, or Hold?
SANA - Sana Biotechnology, Inc. Common Stock
$2.85
0.17 (6.34%)
▲
5d:
+5.95%
30d:
-9.24%
90d:
-12.84%
BUY
MODERATE Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When SANA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SANA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: SANA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SANA is currently trading at $2.85, which is considered slightly low relative to its 30-day fair value range of $2.84 to $3.31.
Technical Outlook: Technically, SANA is in a strong downtrend. Immediate support is located at $2.61, while resistance sits at $3.28. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: SANA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.57 (+200.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SANA is in a strong downtrend. Immediate support is located at $2.61, while resistance sits at $3.28. The stock is showing strong short-term momentum, up 6.3% recently.
Market Sentiment: SANA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $8.57 (+200.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$2.84 -
$3.31
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.3%)
- BULLISH: Trading 200.8% below Wall St target ($8.57)
Trading Range Analysis
30-Day Trading Range
$2.84 -
$3.31
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$2.61
Resistance Level
$3.28
Current Trend
Strong Downtrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.29
Wall Street Target
$8.57
(+200.8%)
Share & Embed Analysis
Last updated: June 15, 2026 9:44 PM ET
Data refreshes hourly during market hours. Next update: 10:44 PM
Data refreshes hourly during market hours. Next update: 10:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SANA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$439 | 57 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1029 | 64 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 50 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$297 | 51 HOLD |
